Investors Research Corp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $405K | Hold |
8,756
| – | – | 0.08% | 221 |
|
|
2025
Q1 | $534K | Sell |
8,756
-413
| -5% | -$25.2K | 0.12% | 180 |
|
|
2024
Q4 | $519K | Hold |
9,169
| – | – | 0.11% | 191 |
|
|
2024
Q3 | $474K | Buy |
9,169
+607
| +7% | +$31.4K | 0.1% | 209 |
|
|
2024
Q2 | $356K | Buy |
8,562
+7,775
| +988% | +$323K | 0.08% | 247 |
|
|
2024
Q1 | $42.7K | Hold |
787
| – | – | 0.01% | 520 |
|
|
2023
Q4 | $40.4K | Hold |
787
| – | – | 0.01% | 535 |
|
|
2023
Q3 | $45.7K | Hold |
787
| – | – | 0.01% | 526 |
|
|
2023
Q2 | $50.3K | Hold |
787
| – | – | 0.01% | 512 |
|
|
2023
Q1 | $54.5K | Hold |
787
| – | – | 0.01% | 518 |
|
|
2022
Q4 | $56.6K | Hold |
787
| – | – | 0.02% | 496 |
|
|
2022
Q3 | $56K | Hold |
787
| – | – | 0.02% | 473 |
|
|
2022
Q2 | $61K | Hold |
787
| – | – | 0.02% | 481 |
|
|
2022
Q1 | $57K | Hold |
787
| – | – | 0.02% | 498 |
|
|
2021
Q4 | $49K | Hold |
787
| – | – | 0.01% | 525 |
|
|
2021
Q3 | $47K | Hold |
787
| – | – | 0.02% | 529 |
|
|
2021
Q2 | $53K | Hold |
787
| – | – | 0.02% | 513 |
|
|
2021
Q1 | $50K | Hold |
787
| – | – | 0.02% | 511 |
|
|
2020
Q4 | $49K | Hold |
787
| – | – | 0.02% | 546 |
|
|
2020
Q3 | $47K | Hold |
787
| – | – | 0.02% | 514 |
|
|
2020
Q2 | $46K | Hold |
787
| – | – | 0.02% | 503 |
|
|
2020
Q1 | $44K | Buy |
787
+18
| +2% | +$1.01K | 0.03% | 467 |
|
|
2019
Q4 | $49K | Buy |
769
+300
| +64% | +$19.1K | 0.02% | 524 |
|
|
2019
Q3 | $24K | Buy |
+469
| New | +$24K | 0.01% | 651 |
|